Homrich & Berg’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $2.63M | Buy |
11,401
+182
| +2% | +$44.9K | 0.06% | 128 |
|
|
2021
Q2 | $2.58M | Buy |
11,219
+97
| +0.9% | +$19.5K | 0.06% | 124 |
|
|
2021
Q1 | $2.08M | Sell |
11,122
-1,255
| -10% | -$245K | 0.05% | 130 |
|
|
2020
Q4 | $2.09M | Buy |
12,377
+568
| +5% | +$84.8K | 0.06% | 117 |
|
|
2020
Q3 | $1.75M | Buy |
11,809
+173
| +1% | +$26.8K | 0.06% | 107 |
|
|
2020
Q2 | $1.91M | Buy |
11,636
+397
| +4% | +$60.9K | 0.08% | 84 |
|
|
2020
Q1 | $1.56M | Sell |
11,239
-28
| -0.2% | -$3.85K | 0.09% | 79 |
|
|
2019
Q4 | $1.48M | Buy |
11,267
+731
| +7% | +$84.7K | 0.07% | 129 |
|
|
2019
Q3 | $1.18M | Sell |
10,536
-133
| -1% | -$14.8K | 0.06% | 136 |
|
|
2019
Q2 | $1.18M | Buy |
10,669
+295
| +3% | +$34.7K | 0.06% | 133 |
|
|
2019
Q1 | $1.35M | Sell |
10,374
-50
| -0.5% | -$6.08K | 0.07% | 106 |
|
|
2018
Q4 | $1.21M | Buy |
10,424
+18
| +0.2% | +$2.01K | 0.07% | 105 |
|
|
2018
Q3 | $1.12M | Sell |
10,406
-31
| -0.3% | -$3.1K | 0.07% | 115 |
|
|
2018
Q2 | $891K | Buy |
10,437
+807
| +8% | +$66.3K | 0.06% | 131 |
|
|
2018
Q1 | $745K | Sell |
9,630
-13,070
| -58% | -$1.05M | 0.05% | 163 |
|
|
2017
Q4 | $1.92M | Sell |
22,700
-67
| -0.3% | -$5.7K | 0.13% | 81 |
|
|
2017
Q3 | $1.95M | Buy |
22,767
+12,002
| +111% | +$984K | 0.15% | 58 |
|
|
2017
Q2 | $886K | Sell |
10,765
-213
| -2% | -$17.4K | 0.08% | 107 |
|
|
2017
Q1 | $923K | Sell |
10,978
-48
| -0.4% | -$3.85K | 0.08% | 107 |
|
|
2016
Q4 | $811K | Buy |
11,026
+604
| +6% | +$45K | 0.07% | 105 |
|
|
2016
Q3 | $836K | Sell |
10,422
-1,931
| -16% | -$155K | 0.08% | 99 |
|
|
2016
Q2 | $973K | Sell |
12,353
-4,432
| -26% | -$334K | 0.09% | 80 |
|
|
2016
Q1 | $1.21M | Sell |
16,785
-70
| -0.4% | -$5.3K | 0.12% | 61 |
|
|
2015
Q4 | $1.42M | Buy |
16,855
+317
| +2% | +$26.3K | 0.13% | 58 |
|
|
2015
Q3 | $1.38M | Sell |
16,538
-2,139
| -11% | -$181K | 0.15% | 56 |
|
|
2015
Q2 | $1.56M | Sell |
18,677
-2,796
| -13% | -$213K | 0.15% | 57 |
|
|
2015
Q1 | $1.56M | Buy |
21,473
+46
| +0.2% | +$3.27K | 0.15% | 56 |
|
|
2014
Q4 | $1.48M | Buy |
21,427
+6,138
| +40% | +$414K | 0.15% | 58 |
|
|
2014
Q3 | $992K | Buy |
15,289
+101
| +0.7% | +$6.39K | 0.1% | 81 |
|
|
2014
Q2 | $944K | Sell |
15,188
-3,000
| -16% | -$179K | 0.11% | 79 |
|
|
2014
Q1 | $1.07M | Buy |
18,188
+4,100
| +29% | +$229K | 0.14% | 70 |
|
|
2013
Q4 | $718K | Buy |
14,088
+1,699
| +14% | +$85.1K | 0.1% | 88 |
|
|
2013
Q3 | $624K | Buy |
12,389
+148
| +1% | +$7.75K | 0.1% | 94 |
|
|
2013
Q2 | $601K | Buy |
+12,241
| New | +$666K | 0.11% | 80 |
|
Other funds holding LLY
Homrich & Berg's LLY Position: Q3 2021 in Review
Homrich & Berg increased its Eli Lilly (LLY) stake by 1.6% in Q3 2021, buying an estimated $44.9K and bringing the position to 11,401 shares worth $2.63M. The position accounts for 0.06% of the portfolio, ranked #128.
Homrich & Berg first reported a position in LLY in Q2 2013 and has held it in 34 quarters since. 2,050 funds tracked by Wall St. Rank hold LLY as of Q3 2021.
- Homrich & Berg held 11,401 shares of Eli Lilly worth $2.63M as of Q3 2021.
- Homrich & Berg bought 182 Eli Lilly shares in Q3 2021, an estimated $44.9K.
- Eli Lilly made up 0.06% of Homrich & Berg's portfolio in Q3 2021, its #128 holding.
- Homrich & Berg first reported a position in Eli Lilly in Q2 2013 and has held it in 34 quarters since.
- 2,050 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2021.
Based on Homrich & Berg's 13F filing for Q3 2021, filed 8 Dec 2021.